Ads
related to: clia list for approved glucometershellolingo.com has been visited by 10K+ users in the past month
wiserlifestyles.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
In November 2007, the CLIA waiver provisions were revised by the United States Congress to make it clear that tests approved by the FDA for home use automatically qualify for CLIA waiver, [21] although many waived tests are not done according to designed protocols – more than 50% of such tests are done incorrectly – and result in medical ...
One noninvasive glucose meter has been approved by the U.S. FDA: The GlucoWatch G2 Biographer made by Cygnus Inc. The device was designed to be worn on the wrist and used electric fields to draw out body fluid for testing. The device did not replace conventional blood glucose monitoring.
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood ().Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, via fingerstick) to draw blood, then applying the blood to a chemically active disposable 'test-strip'.
Medicare covers home-use glucometers under the durable medical equipment (DME) benefit of Part B, which is part of Original Medicare, though there are some exceptions.
Noninvasive glucose monitoring (NIGM), called Noninvasive continuous glucose monitoring when used as a CGM technique, is the measurement of blood glucose levels, required by people with diabetes to prevent both chronic and acute complications from the disease, without drawing blood, puncturing the skin, or causing pain or trauma.
Currently approved CGMs use an enzymatic technology which reacts with glucose molecules in the body's interstitial fluid to generate an electric current that is proportional to glucose concentration. Data about glucose concentration is then relayed from a transmitter attached to the sensor to a receiver and display that shows the data to the user.